George S.G. Shehatou

774 total citations
31 papers, 638 citations indexed

About

George S.G. Shehatou is a scholar working on Epidemiology, Molecular Biology and Nephrology. According to data from OpenAlex, George S.G. Shehatou has authored 31 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Molecular Biology and 6 papers in Nephrology. Recurrent topics in George S.G. Shehatou's work include Liver Disease Diagnosis and Treatment (7 papers), Natural Antidiabetic Agents Studies (4 papers) and Diet, Metabolism, and Disease (4 papers). George S.G. Shehatou is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Natural Antidiabetic Agents Studies (4 papers) and Diet, Metabolism, and Disease (4 papers). George S.G. Shehatou collaborates with scholars based in Egypt, Saudi Arabia and United Kingdom. George S.G. Shehatou's co-authors include Ghada M. Suddеk, Hatem A. Salem, Nariman M. Gameil, Noha M. Shawky, Marwa E. Abdelmageed, Abdelhadi M. Shebl, Mona Abdel Rahim, Eman Said, Manar A. Nader and Rania R. Abdеlaziz and has published in prestigious journals such as Molecular Pharmacology, Life Sciences and European Journal of Pharmacology.

In The Last Decade

George S.G. Shehatou

30 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George S.G. Shehatou Egypt 15 248 101 81 70 68 31 638
Mona F. El-Azab Egypt 18 306 1.2× 76 0.8× 62 0.8× 42 0.6× 62 0.9× 37 790
Yiyi Jin China 16 353 1.4× 66 0.7× 45 0.6× 108 1.5× 38 0.6× 31 747
Xueyan Zhou China 16 494 2.0× 76 0.8× 40 0.5× 54 0.8× 64 0.9× 61 918
Guanzhong Wu China 10 368 1.5× 153 1.5× 88 1.1× 57 0.8× 76 1.1× 24 745
Reem N. El‐Naga Egypt 18 251 1.0× 48 0.5× 43 0.5× 46 0.7× 39 0.6× 32 792
Rong Lin China 16 435 1.8× 44 0.4× 37 0.5× 105 1.5× 75 1.1× 31 783
Huiqin Xu China 17 391 1.6× 125 1.2× 26 0.3× 91 1.3× 57 0.8× 33 861
Sana Irfan Khan India 15 321 1.3× 119 1.2× 21 0.3× 55 0.8× 60 0.9× 31 946
Mohamed K. El-Kherbetawy Egypt 16 196 0.8× 77 0.8× 23 0.3× 39 0.6× 62 0.9× 36 609
Yong‐Yu Yang China 15 456 1.8× 80 0.8× 30 0.4× 60 0.9× 80 1.2× 31 817

Countries citing papers authored by George S.G. Shehatou

Since Specialization
Citations

This map shows the geographic impact of George S.G. Shehatou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George S.G. Shehatou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George S.G. Shehatou more than expected).

Fields of papers citing papers by George S.G. Shehatou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George S.G. Shehatou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George S.G. Shehatou. The network helps show where George S.G. Shehatou may publish in the future.

Co-authorship network of co-authors of George S.G. Shehatou

This figure shows the co-authorship network connecting the top 25 collaborators of George S.G. Shehatou. A scholar is included among the top collaborators of George S.G. Shehatou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George S.G. Shehatou. George S.G. Shehatou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shehatou, George S.G., et al.. (2024). Diltiazem mitigates acute liver injury by targeting NFκB-TXNIP/NLRP3 axis in Rats: New insights beyond calcium channel blockade. International Immunopharmacology. 143(Pt 2). 113460–113460. 2 indexed citations
3.
4.
Shehatou, George S.G., et al.. (2024). Establishment of dexamethasone model as a model for metabolic-associated hepatic injury in male Wistar rats. 7(1). 0–0. 1 indexed citations
5.
Anbar, Hanan S., George S.G. Shehatou, Mona Abdel Rahim, Ghada M. Suddеk, & Nariman M. Gameil. (2023). Evaluation of regression of diabetes-induced nephropathy and vascular dysfunction in rats by Montelukast via antioxidative and anti-inflammatory actions. Journal of Applied Pharmaceutical Science. 2 indexed citations
6.
Saleh, Mohamed A., Ahmed A. Shaaban, Iman M. Talaat, et al.. (2023). RhoA/ROCK inhibition attenuates endothelin-1–induced glomerulopathy in the rats. Life Sciences. 323. 121687–121687. 5 indexed citations
7.
Abdеlaziz, Rania R., et al.. (2023). Saroglitazar mitigated NASH-associated hepatic injury in dexamethasone-treated rats via modulating autophagy, apoptosis, and necroptosis. Toxicology and Applied Pharmacology. 482. 116774–116774. 2 indexed citations
8.
Shehatou, George S.G., et al.. (2021). Flavocoxid Ameliorates Aortic Calcification Induced by Hypervitaminosis D3 and Nicotine in Rats Via Targeting TNF-α, IL-1β, iNOS, and Osteogenic Runx2. Cardiovascular Drugs and Therapy. 36(6). 1047–1059. 4 indexed citations
9.
Shehatou, George S.G., et al.. (2021). Dasatinib mitigates renal fibrosis in a rat model of UUO via inhibition of Src/STAT-3/NF-κB signaling. Environmental Toxicology and Pharmacology. 84. 103625–103625. 11 indexed citations
10.
Said, Eman, et al.. (2021). Nifuroxazide suppresses UUO-induced renal fibrosis in rats via inhibiting STAT-3/NF-κB signaling, oxidative stress and inflammation. Life Sciences. 272. 119241–119241. 34 indexed citations
11.
Abdelmageed, Marwa E., George S.G. Shehatou, Ghada M. Suddеk, & Hatem A. Salem. (2020). Protocatechuic acid improves hepatic insulin resistance and restores vascular oxidative status in type-2 diabetic rats. Environmental Toxicology and Pharmacology. 83. 103577–103577. 42 indexed citations
12.
Shehatou, George S.G., et al.. (2018). Levocetirizine Pretreatment Mitigates Lipopolysaccharide-Induced Lung Inflammation in Rats. BioMed Research International. 2018. 1–9. 14 indexed citations
13.
Shawky, Noha M., George S.G. Shehatou, Ghada M. Suddеk, & Nariman M. Gameil. (2018). Comparison of the effects of sulforaphane and pioglitazone on insulin resistance and associated dyslipidemia, hepatosteatosis, and endothelial dysfunction in fructose-fed rats. Environmental Toxicology and Pharmacology. 66. 43–54. 29 indexed citations
14.
Shehatou, George S.G., et al.. (2018). Cinnamaldehyde exerts vasculoprotective effects in hypercholestrolemic rabbits. Naunyn-Schmiedeberg s Archives of Pharmacology. 391(11). 1203–1219. 18 indexed citations
15.
Shehatou, George S.G., et al.. (2017). Antioxidant and anti-inflammatory effects of dimethyl fumarate in hypercholesterolemic rabbits. Egyptian Journal of Basic and Applied Sciences. 4(3). 153–159. 13 indexed citations
16.
Anbar, Hanan S., George S.G. Shehatou, Ghada M. Suddеk, & Nariman M. Gameil. (2016). Comparison of the effects of levocetirizine and losartan on diabetic nephropathy and vascular dysfunction in streptozotocin-induced diabetic rats. European Journal of Pharmacology. 780. 82–92. 22 indexed citations
17.
Bayomi, Said M., Magda A. El‐Sherbeny, Naglaa I. Abdel-Aziz, et al.. (2016). Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibition activities and molecular docking study of pyrazoline derivatives. Bioorganic & Medicinal Chemistry. 24(9). 2032–2042. 69 indexed citations
18.
Shehatou, George S.G., et al.. (2016). Febuxostat exerts dose-dependent renoprotection in rats with cisplatin-induced acute renal injury. Naunyn-Schmiedeberg s Archives of Pharmacology. 389(8). 819–830. 20 indexed citations
19.
Shehatou, George S.G. & Ghada M. Suddеk. (2015). Sulforaphane attenuates the development of atherosclerosis and improves endothelial dysfunction in hypercholesterolemic rabbits. Experimental Biology and Medicine. 241(4). 426–436. 51 indexed citations
20.
Shehatou, George S.G., Susan Giblett, Christine E. Pullar, et al.. (2014). Long-Term Channel Block Is Required to Inhibit Cellular Transformation by Human Ether-à-Go-Go–Related Gene (hERG1) Potassium Channels. Molecular Pharmacology. 86(2). 211–221. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mona F. El-Azab Breakdown of academic impact, for papers by Yiyi Jin Breakdown of academic impact, for papers by Xueyan Zhou Breakdown of academic impact, for papers by Guanzhong Wu Breakdown of academic impact, for papers by Reem N. El‐Naga Breakdown of academic impact, for papers by Rong Lin Breakdown of academic impact, for papers by Huiqin Xu Breakdown of academic impact, for papers by Sana Irfan Khan Breakdown of academic impact, for papers by Mohamed K. El-Kherbetawy Breakdown of academic impact, for papers by Yong‐Yu Yang
Rankless by CCL
2026